[VIR] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[VIR] Vir Biotechnology, Inc.
Announcement Date
26-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- 29.03%
YoY- -14.14%
Quarter Report
VIR's Result
VIR's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 16,787 21,789 809,756 301 371 6 388.63%
PBT -120,757 -151,638 545,889 -105,679 -63,622 -26,373 35.54%
Tax -4,784 -50,035 20,635 -30 149 20 -
NP -115,973 -101,603 525,254 -105,649 -63,771 -26,393 34.43%
Tax Rate - - -3.78% - - - -
Total Cost 132,760 123,392 284,502 105,950 64,142 26,399 38.10%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -690.85 -466.30 64.87 -35,099.34 -17,188.95 -439,883.33 -72.48%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -0.86 -0.76 4.01 -0.83 -0.69 -0.27 26.05%
EPS Diluted -0.86 -0.76 3.92 -0.83 -0.69 -0.27 26.05%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.